RESUMEN
NSG-SGM3 and NOG-EXL mice combine severe immunodeficiency with transgenic expression of human myeloid stimulatory cytokines, resulting in marked expansion of myeloid populations upon humanization with CD34+ hematopoietic stem cells (HSCs). Humanized NSG-SGM3 mice typically develop a lethal macrophage activation syndrome and mast cell hyperplasia that limit their use in long-term studies (e.g., humanization followed by tumor xenotransplantation). It is currently unclear to what extent humanized NOG-EXL mice suffer from the same condition observed in humanized NSG-SGM3 mice. We compared the effects of human CD34+ HSC engraftment in these two strains in an orthotopic patient-derived glioblastoma model. NSG-SGM3 mice humanized in-house were compared to NOG-EXL mice humanized in-house and commercially available humanized NOG-EXL mice. Mice were euthanized at humane or study endpoints, and complete pathological assessments were performed. A semiquantitative multiparametric clinicopathological scoring system was developed to characterize chimeric myeloid cell hyperactivation (MCH) syndrome. NSG-SGM3 mice were euthanized at 16 weeks after humanization because of severe deterioration of clinical conditions. Humanized NOG-EXL mice survived to the study endpoint at 22 weeks after humanization and showed less-severe MCH phenotypes than NSG-SGM3 mice. Major differences included the lack of mast cell expansion and limited tissue/organ involvement in NOG-EXL mice compared to NSG-SGM3 mice. Engraftment of human lymphocytes, assessed by immunohistochemistry, was similar in the two strains. The longer survival and decreased MCH phenotype severity in NOG-EXL mice enabled their use in a tumor xenotransplantation study. The NOG-EXL model is better suited than the NSG-SGM3 model for immuno-oncology studies requiring long-term survival after humanization.
Asunto(s)
Antígenos CD34 , Trasplante de Células Madre Hematopoyéticas , Células Madre Hematopoyéticas , Ratones Transgénicos , Células Mieloides , Animales , Ratones , Humanos , Células Madre Hematopoyéticas/patología , Antígenos CD34/metabolismo , Células Mieloides/patología , Fenotipo , Modelos Animales de EnfermedadRESUMEN
The spectrum of background, incidental, and experimentally induced lesions affecting NSG and NOG mice has been the subject of intense investigation. However, comprehensive studies focusing on the spontaneous neuropathological changes of these immunocompromised strains are lacking. This work describes the development of spontaneous early-onset neurodegeneration affecting both juvenile and adult NSG, NOG, and NXG mice. The study cohort consisted of 367 NSG mice of both sexes (including 33 NSG-SGM3), 61 NOG females (including 31 NOG-EXL), and 4 NXG females. These animals were primarily used for preclinical CAR T-cell testing, generation of humanized immune system chimeras, and/or tumor xenograft transplantation. Histopathology of brain and spinal cord and immunohistochemistry (IHC) for AIF-1, GFAP, CD34, and CD45 were performed. Neurodegenerative changes were observed in 57.6% of the examined mice (affected mice age range was 6-36 weeks). The lesions were characterized by foci of vacuolation with neuronal degeneration/death and gliosis distributed throughout the brainstem and spinal cord. IHC confirmed the development of gliosis, overexpression of CD34, and a neuroinflammatory component comprised of CD45-positive monocyte-derived macrophages. Lesions were significantly more frequent and severe in NOG mice. NSG males were considerably more affected than NSG females. Increased lesion frequency and severity in older animals were also identified. These findings suggest that NSG, NOG, and NXG mice are predisposed to the early development of identical neurodegenerative changes. While the cause of these lesions is currently unclear, potential associations with the genetic mutations shared by NSG, NOG, and NXG mice as well as unidentified viral infections are considered.
Asunto(s)
Neoplasias , Masculino , Femenino , Ratones , Animales , Gliosis/veterinaria , Neoplasias/veterinaria , Tronco Encefálico , Médula Espinal , Ratones SCIDRESUMEN
Ongoing clinical trials for treatment of beta-globinopathies by gene therapy involve the transfer of the beta-globin gene, which requires integration of three to four copies per genome in most target cells. This high proviral load may increase genome toxicity, potentially limiting the safety of this therapy and relegating its use to total body myeloablation. We hypothesized that introducing an additional hypersensitive site from the locus control region, the complete sequence of the second intron of the beta-globin gene, and the ankyrin insulator may enhance beta-globin expression. We identified a construct, ALS20, that synthesized significantly higher adult hemoglobin levels than those of other constructs currently used in clinical trials. These findings were confirmed in erythroblastic cell lines and in primary cells isolated from sickle cell disease patients. Bone marrow transplantation studies in beta-thalassemia mice revealed that ALS20 was curative at less than one copy per genome. Injection of human CD34+ cells transduced with ALS20 led to safe, long-term, and high polyclonal engraftment in xenograft experiments. Successful treatment of beta-globinopathies with ALS20 could potentially be achieved at less than two copies per genome, minimizing the risk of cytotoxic events and lowering the intensity of myeloablation.
Asunto(s)
Anemia de Células Falciformes/genética , Trasplante de Médula Ósea , Terapia Genética , Globinas beta/genética , Talasemia beta/genética , Anemia de Células Falciformes/sangre , Anemia de Células Falciformes/patología , Anemia de Células Falciformes/terapia , Animales , Expresión Génica/genética , Vectores Genéticos/genética , Vectores Genéticos/farmacología , Hemoglobinas/genética , Xenoinjertos , Humanos , Lentivirus/genética , Región de Control de Posición/genética , Ratones , Transducción Genética , Globinas beta/uso terapéutico , Talasemia beta/sangre , Talasemia beta/patología , Talasemia beta/terapiaRESUMEN
Balancing cell survival and cell death is fundamental to development and homeostasis. Cell death is regulated by multiple interconnected signaling pathways and molecular mechanisms. Regulated cell death (RCD) is implicated in fundamental processes such as organogenesis and tissue remodeling, removal of unnecessary structures or cells, and regulation of cell numbers. RCD can also be triggered by exogenous perturbations of the intracellular or extracellular microenvironment when the adaptive processes that respond to stress fail. During the past few years, many novel forms of non-apoptotic RCD have been identified, and the characterization of RCD mechanisms at a molecular level has deepened our understanding of diseases encountered in human and veterinary medicine. Given the complexity of these processes, it has become clear that the identification of RCD cannot be based simply on morphologic characteristics and that descriptive and diagnostic terms presently used by pathologists-such as individual cell apoptosis or necrosis-appear inadequate and possibly misleading. In this review, the current understanding of the molecular machinery of each type of non-apoptotic RCD mechanisms is outlined. Due to the continuous discovery of new mechanisms or nuances of previously described processes, the limitations of the terms apoptosis and necrosis to indicate microscopic findings are also reported. In addition, the need for a standard panel of biomarkers and functional tests to adequately characterize the underlying RCD and its role as a mechanism of disease is considered.
Asunto(s)
Muerte Celular Regulada , Animales , Apoptosis , Muerte Celular , Necrosis/veterinaria , Transducción de SeñalRESUMEN
A 13 yr old spayed female Yorkshire terrier was hospitalized for a dull mentation, anorexia, presumptive gastroenterocolitis, and a suspected gastrointestinal bleed with melena. Despite supportive therapy, the patient's clinical signs persisted. Throughout hospitalization, the patient became progressively dull to stuporous with a progressive hypernatremia. On day 3 of hospitalization, the patient acutely developed neurological signs with a neuroanatomical localization consistent with a process at the caudal cranial fossa. Per the owner's wishes, the patient was euthanized with necropsy performed. Histopathology revealed a suppurative meningoencephalitis, ventriculitis, hypophysitis, otitis interna, and an ulcerative pharyngitis. Aerobic culture collected from the area of the pituitary gland grew an Enterococcus spp. Enterococcal meningoencephalitis is rare in humans but has not been reported in veterinary medicine. In future cases of canine bacterial meningitis, Enterococcus spp. should be considered. Because of the inherent resistance patterns of Enterococcus spp., targeted antibiotic selection would be required for treatment.
Asunto(s)
Ventriculitis Cerebral , Enfermedades de los Perros , Hipofisitis , Meningoencefalitis , Animales , Ventriculitis Cerebral/veterinaria , Enfermedades de los Perros/diagnóstico , Enfermedades de los Perros/tratamiento farmacológico , Perros , Enterococcus , Femenino , Humanos , Hipofisitis/veterinaria , Meningoencefalitis/diagnóstico , Meningoencefalitis/tratamiento farmacológico , Meningoencefalitis/veterinariaRESUMEN
Sharp superconducting transition anomalies observed in a new generation of single crystals establish that bulk superconductivity is intrinsic to high purity YFe_{2}Ge_{2}. Low temperature heat capacity measurements suggest a disorder and field dependent residual Sommerfeld coefficient, consistent with disorder-induced in-gap states as expected for a sign-changing order parameter. The sevenfold reduction in disorder scattering in these new crystals to residual resistivities ≃0.45 µΩ cm was achieved using a new liquid transport growth technique, paving the way for multiprobe experiments investigating the normal and superconducting states of YFe_{2}Ge_{2}.
RESUMEN
Genetically engineered mouse lines on a C57BL/6J background are widely employed as preclinical models to study neurodegenerative human disorders and brain tumors. However, because of the lack of comprehensive data on the spontaneous background neuropathology of the C57BL/6J strain, discriminating between naturally occurring changes and lesions caused by experimental mutations can be challenging. In this context, this study aims at defining the spectrum and frequency of spontaneous brain changes in a large cohort of C57BL/6J mice and their association with specific biological variables, including age and sex. Brains from 203 experimentally naive and clinically unremarkable C57BL/6J mice were collected and analyzed by means of histopathology and immunohistochemistry. Mice ranged in age from 3 to 110 weeks with 89 females, 111 males, and 3 unknowns. Sixteen different spontaneous lesion categories were described in this cohort. Age-related neurodegenerative and/or neuroinflammatory findings represented the most common pathologic changes and included (1) Hirano-like inclusions in the thalamic neurons, (2) neuroaxonal dystrophy in the medulla oblongata, (3) periodic acid-Schiff-positive granular deposits in the neuropil of the hippocampus, and (4) progressive neuroinflammation characterized by microgliosis and astrogliosis. Neoplastic conditions, developmental abnormalities, and circulatory disorders were rarely observed incidental findings. In conclusion, this study describes spontaneous age-related brain lesions of the C57BL/6J mouse and provides a reference for evaluating and interpreting the neuropathological phenotype in genetically engineered mouse models developed and maintained on this congenic background.
Asunto(s)
Envejecimiento/patología , Distrofias Neuroaxonales/veterinaria , Enfermedades Neurodegenerativas/veterinaria , Enfermedades de los Roedores/patología , Animales , Encéfalo/patología , Femenino , Cuerpos de Inclusión/patología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Distrofias Neuroaxonales/patología , Enfermedades Neurodegenerativas/patología , Neuronas/patología , FenotipoRESUMEN
Nasal polyps in dogs are space-occupying soft-tissue masses that have been encountered concurrently with intranasal neoplasia in surgical biopsy specimens. The proportion of nasal polyp co-occurrence with primary nasal tumors was examined, and follow-up biopsies on dogs initially diagnosed with nasal polyp were reviewed. Histologic sections from 321 cases of intranasal neoplasia and 50 cases of nasal polyp from 2004 to 2017 were reviewed. Of the 321 cases of intranasal neoplasia, 51 (16%) had concurrent nasal polyps, and most of these (47/51) had intranasal carcinoma. Twenty-five of the 50 dogs with a primary diagnosis of nasal polyp were rebiopsied, and the diagnoses in these subsequent biopsies were nasal polyp in 15, malignant neoplasm in 9, and intranasal nematode in 1. Nasal polyps occurred frequently in conjunction with nasal carcinoma. In dogs with a diagnosis of nasal polyp, repeat biopsy to reveal possible neoplasia is warranted.
Asunto(s)
Enfermedades de los Perros/diagnóstico , Pólipos Nasales/veterinaria , Neoplasias Nasales/veterinaria , Animales , Enfermedades de los Perros/patología , Perros , Femenino , Masculino , Cavidad Nasal/patología , Pólipos Nasales/complicaciones , Pólipos Nasales/diagnóstico , Pólipos Nasales/patología , Neoplasias Nasales/complicaciones , Neoplasias Nasales/diagnóstico , Neoplasias Nasales/patologíaRESUMEN
When advising farmers on how to control Johne's disease in an infected herd, one of the main recommendations is to avoid feeding waste milk to calves and instead feed calf milk replacer (CMR). This advice is based on the assumption that CMR is free of viable Mycobacterium avium ssp. paratuberculosis (MAP) cells, an assumption that has not previously been challenged. We tested commercial CMR products (n = 83) obtained from dairy farms around the United States by the peptide-mediated magnetic separation (PMS)-phage assay, PMS followed by liquid culture (PMS-culture), and direct IS900 quantitative PCR (qPCR). Conventional microbiological analyses for total mesophilic bacterial counts, coliforms, Salmonella, coagulase-negative staphylococci, streptococci, nonhemolytic Corynebacterium spp., and Bacillus spp. were also performed to assess the overall microbiological quality of the CMR. Twenty-six (31.3%) of the 83 CMR samples showed evidence of the presence of MAP. Seventeen (20.5%) tested positive for viable MAP by the PMS-phage assay, with plaque counts ranging from 6 to 1,212 pfu/50 mL of reconstituted CMR (average 248.5 pfu/50 mL). Twelve (14.5%) CMR samples tested positive for viable MAP by PMS-culture; isolates from all 12 of these samples were subsequently confirmed by whole-genome sequencing to be different cattle strains of MAP. Seven (8.4%) CMR samples tested positive for MAP DNA by IS900 qPCR. Four CMR samples tested positive by both PMS-based tests and 5 CMR samples tested positive by IS900 qPCR plus one or other of the PMS-based tests, but only one CMR sample tested positive by all 3 MAP detection tests applied. All conventional microbiology results were within current standards for whole milk powders. A significant association existed between higher total bacterial counts and presence of viable MAP indicated by either of the PMS-based assays. This represents the first published report of the isolation of viable MAP from CMR. Our findings raise concerns about the potential ability of MAP to survive manufacture of dried milk-based products.
Asunto(s)
Alimentación Animal/microbiología , Enfermedades de los Bovinos/epidemiología , ADN Bacteriano/análisis , Industria Lechera/métodos , Mycobacterium avium subsp. paratuberculosis/aislamiento & purificación , Paratuberculosis/epidemiología , Reacción en Cadena de la Polimerasa/métodos , Animales , Bovinos , Enfermedades de los Bovinos/microbiología , Dieta/veterinaria , Higiene , Paratuberculosis/microbiología , Wisconsin/epidemiologíaRESUMEN
The cellulose-rich walls that protect plant cells are difficult to digest, and therefore mechanical food processing is a key aspect of herbivory across vertebrates. Cell walls are typically broken down by translation of flattened teeth in the occlusal plane (i.e. grinding) as part of a complex, rhythmic chewing stroke. The grass carp, Ctenopharyngodon idella, is a voracious, invasive herbivorous fish that relies solely on its pharyngeal teeth, located in the back of the throat, for mechanical processing of plant material. Here, we describe the musculoskeletal anatomy of the pharyngeal jaws of grass carp and use XROMM to quantify chewing kinematics and muscle strain. The pharyngeal jaws are suspended in a sling of 11 muscles and maintain no bony articulation with any other skeletal elements in the head. The jaws bear long, serrated teeth that are worn during use into flattened tooth cusps. Our kinematic data show that this wear is the result of the teeth being elevated into occlusion against the basioccipital process and keratinous chewing pad, not tooth-on-tooth occlusion. Pharyngeal jaw elevation results from large strains in the jaw elevator muscle, the levator arcus branchialis V, to drive a pulley-like mechanism that rotates the jaws about a pivot point at the symphysis between the left and right pharyngeal jaws. These complex, rhythmic jaw rotations translate the teeth laterally across the chewing surface throughout the occlusion phase. The grass carp chewing system is strikingly similar in gross morphology and masticatory function to herbivorous chewing strategies in other vertebrates.
Asunto(s)
Fenómenos Biomecánicos/fisiología , Carpas/anatomía & histología , Mandíbula/anatomía & histología , Masticación , Sistema Musculoesquelético/anatomía & histología , Faringe/anatomía & histología , Diente/anatomía & histología , Animales , Carpas/fisiología , Herbivoria , Mandíbula/fisiología , Faringe/fisiologíaRESUMEN
The discovery and potency optimization of a series of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1 is described. Micromolar hits taken from high-throughput screening were optimized for biochemical and cellular mechanistic potency to ~10nM, as exemplified by compound 12az. Application of structure-based drug design aided by co-crystal structures of TAK1 with inhibitors significantly shortened the number of iterations required for the optimization.
Asunto(s)
Quinasas Quinasa Quinasa PAM/antagonistas & inhibidores , Piridinas , Aminas/síntesis química , Aminas/química , Aminas/farmacología , Animales , Cristalografía por Rayos X , Diseño de Fármacos , Activación Enzimática/efectos de los fármacos , Inhibidores Enzimáticos/síntesis química , Inhibidores Enzimáticos/farmacocinética , Inhibidores Enzimáticos/farmacología , Furanos/síntesis química , Furanos/química , Furanos/farmacología , Humanos , Concentración 50 Inhibidora , Ratones , Estructura Molecular , Neoplasias/tratamiento farmacológico , Piridinas/síntesis química , Piridinas/farmacocinética , Piridinas/farmacología , Relación Estructura-Actividad , Ensayos Antitumor por Modelo de XenoinjertoRESUMEN
Crigler-Najjar syndrome is a rare disorder of bilirubin metabolism caused by uridine diphosphate glucuronosyl transferase 1A1 (UGT1A1) mutations characterized by hyperbilirubinemia and jaundice. No cure currently exists; treatment options are limited to phototherapy, whose effectiveness diminishes over time, and liver transplantation. Here, we evaluated the therapeutic potential of systemically administered, lipid nanoparticle-encapsulated human UGT1A1 (hUGT1A1) mRNA therapy in a Crigler-Najjar mouse model. Ugt1 knockout mice were rescued from lethal post-natal hyperbilirubinemia by phototherapy. These adult Ugt1 knockout mice were then administered a single lipid nanoparticle-encapsulated hUGT1A1 mRNA dose. Within 24 h, serum total bilirubin levels decreased from 15 mg/dL (256 µmol/L) to <0.5 mg/dL (9 µmol/L), i.e., slightly above wild-type levels. This reduction was sustained for 2 weeks before bilirubin levels rose and returned to pre-treatment levels by day 42 post-administration. Sustained reductions in total bilirubin levels were achieved by repeated administration of the mRNA product in a frequency-dependent manner. We were also able to rescue the neonatal lethality phenotype seen in Ugt1 knockout mice with a single lipid nanoparticle dose, which suggests that this may be a treatment modality appropriate for metabolic crisis situations. Therefore, lipid nanoparticle-encapsulated hUGT1A1 mRNA may represent a potential treatment for Crigler-Najjar syndrome.
RESUMEN
Routine handling and manipulation of laboratory mice are integral components of most preclinical studies. Any type of handling and manipulation may cause stress and result in physical harm to mice, potentially leading to unintended consequences of experimental outcomes. Nevertheless, the pathological effects of these interventions are poorly documented and assumed to have a negligible effect on experimental variables. In that context, we provide a comprehensive post mortem overview of the main pathological changes associated with routine interventions (i.e., restraint, blood drawing, and intraperitoneal injections) of laboratory mice with an emphasis on presumed traumatic osteoarticular lesions. A total of 1000 mice from various studies were included, with 864 animals being heavily manipulated and 136 being handled for routine husbandry procedures only. The most common lesions observed were associated with blood collection or intraperitoneal injections, as well as a series of traumatic osteoarticular lesions likely resulting from restraint. Osteoarticular lesions were found in 62 animals (61 heavily manipulated; 1 unmanipulated) with rib fractures and avulsion of the dens of the axis being over-represented. Histopathology and micro-CT confirmed the traumatic nature of the rib fractures. While these lesions might be unavoidable if mice are manipulated according to the current standards, intentional training of research personnel on appropriate mouse handling and restraint techniques could help reduce their frequency and the impact on animal wellbeing as well as study reproducibility.
RESUMEN
IL-33 is an alarmin required for resistance to the parasite Toxoplasma gondii, but its role in innate resistance to this organism is unclear. Infection with T. gondii promotes increased stromal cell expression of IL-33, and levels of parasite replication correlate with release of IL-33 in affected tissues. In response to infection, a subset of innate lymphoid cells (ILC) emerges composed of IL-33R+ NK cells and ILC1s. In Rag1-/-mice, where NK cells and ILC1 production of IFN-γ mediate innate resistance to T. gondii, the loss of the IL-33R resulted in reduced ILC responses and increased parasite replication. Furthermore, administration of IL-33 to Rag1-/- mice resulted in a marked decrease in parasite burden, increased production of IFN-γ, and the recruitment and expansion of inflammatory monocytes associated with parasite control. These protective effects of exogenous IL-33 were dependent on endogenous IL-12p40 and the ability of IL-33 to enhance ILC production of IFN-γ. These results highlight that IL-33 synergizes with IL-12 to promote ILC-mediated resistance to T. gondii.
Asunto(s)
Interferón gamma/inmunología , Interleucina-33/inmunología , Linfocitos/inmunología , Toxoplasma/inmunología , Toxoplasmosis/inmunología , Animales , Femenino , Humanos , Inmunidad Innata , Interferón gamma/genética , Interleucina-33/genética , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Toxoplasma/genética , Toxoplasmosis/genética , Toxoplasmosis/parasitologíaRESUMEN
"Humanized" immunodeficient mice generated via the transplantation of CD34+ human hematopoietic stem cells (hHSC) are an important preclinical model system. The triple transgenic NOD.Cg-PrkdcscidIl2rgtm1Wjl Tg(CMV-IL3,CSF2,KITLG)1Eav/MloySzJ (NSGS) mouse line is increasingly used as recipient for CD34+ hHSC engraftment. NSGS mice combine the features of the highly immunodeficient NSG mice with transgenic expression of the human myeloid stimulatory cytokines GM-CSF, IL-3, and Kit ligand. While generating humanized NSGS (huNSGS) mice from two independent cohorts, we encountered a fatal macrophage activation syndrome (MAS)-like phenotype resulting from the transplantation of CD34+ hHSC. huNSGS mice exhibiting this phenotype declined clinically starting at approximately 10 weeks following CD34+ hHSC engraftment, with all mice requiring euthanasia by 16 weeks. Gross changes comprised small, irregular liver, splenomegaly, cardiomegaly, and generalized pallor. Hematological abnormalities included severe thrombocytopenia and anemia. Pathologically, huNSGS spontaneously developed a disseminated histiocytosis with infiltrates of activated macrophages and hemophagocytosis predominantly affecting the liver, spleen, bone marrow, and pancreas. The infiltrates were chimeric with a mixture of human and mouse macrophages. Immunohistochemistry suggested activation of the inflammasome in both human and murine macrophages. Active Epstein-Barr virus infection was not a feature. Although the affected mice exhibited robust chimerism of the spleen and bone marrow, the phenotype often developed in the face of low chimerism of the peripheral blood. Given the high penetrance and early lethality associated with the MAS-like phenotype here described, we urge caution when considering the use of huNSGS mice for the development of long-term studies.
Asunto(s)
Síndrome de Activación Macrofágica/patología , Macrófagos/microbiología , Animales , Antígenos CD34 , Proteína Quinasa Activada por ADN/inmunología , Infecciones por Virus de Epstein-Barr/inmunología , Factor Estimulante de Colonias de Granulocitos y Macrófagos/inmunología , Trasplante de Células Madre Hematopoyéticas , Células Madre Hematopoyéticas/citología , Células Madre Hematopoyéticas/metabolismo , Herpesvirus Humano 4 , Histiocitosis/inmunología , Humanos , Subunidad gamma Común de Receptores de Interleucina/inmunología , Síndrome de Activación Macrofágica/inmunología , Masculino , Ratones , Ratones Endogámicos NOD , Ratones SCID , Proteínas Recombinantes/inmunología , Factor de Células Madre/inmunologíaRESUMEN
Mixed germ cell tumours occur rarely in veterinary species. This report describes a case of metastatic mixed germ cell tumour in a female Eurasian harvest mouse (Micromys minutus). The tumour was extensive in one ovary and the uterus, and was characterized by two distinct tumour cell populations with features typical of embryonal carcinoma (EC) and choriocarcinoma (CC). Metastases of CC to the lungs and liver were observed. The exact origin of the CC was unclear, but the possibility of a non-gestational CC is favoured, given the context of a mixed germ cell tumour and lack of p53 expression. EC diagnosis was confirmed by immunohistochemical labelling of CD30 and lack of immunoreactivity for c-Kit. In addition, membranous ß-catenin expression was present in the EC component, indicating an inactive Wnt/ß-catenin pathway, which is required for the maintenance of pluripotency.
Asunto(s)
Carcinoma Embrionario , Coriocarcinoma , Neoplasias de Células Germinales y Embrionarias , Enfermedades de los Roedores , Animales , Carcinoma Embrionario/veterinaria , Coriocarcinoma/veterinaria , Femenino , Antígeno Ki-1 , Ratones , Neoplasias de Células Germinales y Embrionarias/veterinariaRESUMEN
The 2008 election brought sweeping political change to Washington, DC. For a variety of reasons, there is also substantial political momentum for reform of our health care system. At the 2008 Association of American Medical Colleges meeting in San Antonio, Texas, the Association of Academic Chairs of Emergency Medicine, meeting in conjunction with the Society for Academic Emergency Medicine, chose to examine the topic of "advocacy and political influence." This article summarizes comments made at the meeting and develops the argument that expertise in health policy and political advocacy are valuable skills that should be considered legitimate components of scholarly activity in academic emergency medicine. Strategies for effective advocacy of issues relevant to emergency medicine and emergency patient care are also discussed.
Asunto(s)
Medicina de Emergencia , Reforma de la Atención de Salud/legislación & jurisprudencia , Política de Salud/legislación & jurisprudencia , Política , Congresos como Asunto , Humanos , Estados UnidosRESUMEN
Novel C-5 aminomethyl pyrrolotriazines were prepared and optimized for dual EGFR and HER2 protein tyrosine kinase inhibition. The homopiperazine, 1p, emerged as a key lead and it showed promising oral efficacy in EGFR and dual EGFR/HER2 driven human tumor xenograft models. It is hypothesized that the C-5 homopiperazine side chain binds in the ribose-phosphate portion of the ATP binding pocket.
Asunto(s)
Antineoplásicos/farmacología , Receptores ErbB/antagonistas & inhibidores , Metilaminas/farmacología , Proteínas Tirosina Quinasas/antagonistas & inhibidores , Pirroles/farmacología , Receptor ErbB-2/antagonistas & inhibidores , Triazinas/farmacología , Animales , Línea Celular Tumoral , Modelos Animales de Enfermedad , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Metilaminas/química , Ratones , Modelos Moleculares , Estructura Molecular , Trasplante de Neoplasias , Pirroles/química , Relación Estructura-Actividad , Triazinas/química , Ensayos Antitumor por Modelo de XenoinjertoRESUMEN
Pyrrolotriazine dual EGFR/HER2 kinase inhibitors with a 5-((4-aminopiperidin-1-yl)methyl) solubilizing group were found to be superior to analogs with previously reported C-5 solubilizing groups. New synthetic methodology was developed for the parallel synthesis of C-4 analogs with the new solubilizing group. Interesting new leads were evaluated in tumor xenograft models and the C-4 aminofluorobenzylindazole, 1c, was found to exhibit the best antitumor activity. It is hypothesized that this solubilizing group extends into the ribose-phosphate portion of the ATP binding pocket and enhances the binding affinity of the inhibitor.
Asunto(s)
Química Farmacéutica/métodos , Receptores ErbB/química , Neoplasias/tratamiento farmacológico , Piperidinas/síntesis química , Pirroles/síntesis química , Receptor ErbB-2/química , Triazinas/síntesis química , Adenosina Trifosfato/metabolismo , Animales , Antineoplásicos/farmacología , Línea Celular Tumoral , Diseño de Fármacos , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Concentración 50 Inhibidora , Insectos , Modelos Químicos , Trasplante de Neoplasias , Piperidinas/química , Piperidinas/farmacología , Pirroles/química , Pirroles/farmacología , Triazinas/química , Triazinas/farmacologíaRESUMEN
Novel C-5 substituted pyrrolotriazines were optimized for dual EGFR and HER2 protein tyrosine kinase inhibition. The lead compound exhibited promising oral efficacy in both EGFR and HER2 driven human tumor xenograft models. It is hypothesized that its C-5 morpholine side chain binds in the ribose phosphate portion of the ATP binding pocket.